Stay updated on PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Sign up to get notified when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.

Latest updates to the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page
- ChecktodayChange DetectedThe site revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check7 days agoChange DetectedThe page adds a glossary toggle and makes minor metadata edits (e.g., Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while deletions adjust capitalization and an older revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.4 is now shown, replacing v3.3.3; this appears to be an internal version update with no visible changes to the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedVirginia has been added under Locations as a study site; the page revision is updated to v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.2%

- Check72 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no visible changes to the study details, eligibility criteria, locations, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoved the temporary government funding status notice from the page, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.